Interleukin-6 Response to Exercise and High-altitude Exposure: Influence of Alpha-adrenergic Blockade
Overview
Affiliations
Interleukin-6 (IL-6), an important cytokine involved in a number of biological processes, is consistently elevated during periods of stress. The mechanisms responsible for the induction of IL-6 under these conditions remain uncertain. This study examined the effect of alpha-adrenergic blockade on the IL-6 response to acute and chronic high-altitude exposure in women both at rest and during exercise. Sixteen healthy, eumenorrheic women (aged 23.2 +/- 1.4 yr) participated in the study. Subjects received either alpha-adrenergic blockade (prazosin, 3 mg/day) or a placebo in a double-blinded, randomized fashion. Subjects participated in submaximal exercise tests at sea level and on days 1 and 12 at altitude (4,300 m). Resting plasma and 24-h urine samples were collected throughout the duration of the study. At sea level, no differences were found at rest for plasma IL-6 between groups (1.5 +/- 0.2 and 1.2 +/- 0.3 pg/ml for placebo and blocked groups, respectively). On acute ascent to altitude, IL-6 levels increased significantly in both groups compared with sea-level values (57 and 84% for placebo and blocked groups, respectively). After 12 days of acclimatization, IL-6 levels remained elevated for placebo subjects; however, they returned to sea-level values in the blocked group. alpha-Adrenergic blockade significantly lowered the IL-6 response to exercise both at sea level (46%) and at altitude (42%) compared with placebo. A significant correlation (P = 0.004) between resting IL-6 and urinary norepinephrine excretion rates was found over the course of time while at altitude. In conclusion, the results indicate a role for alpha-adrenergic regulation of the IL-6 response to the stress of both short-term moderate-intensity exercise and hypoxia.
Recommendations for Women in Mountain Sports and Hypoxia Training/Conditioning.
Burtscher J, Raberin A, Brocherie F, Malatesta D, Manferdelli G, Citherlet T Sports Med. 2023; 54(4):795-811.
PMID: 38082199 PMC: 11052836. DOI: 10.1007/s40279-023-01970-6.
Treatment of recurrent hunting-associated respiratory distress episodes in 2 dogs.
Dumont R, Touzet C, Gomes E, Le Boedec K J Vet Intern Med. 2023; 37(6):2514-2519.
PMID: 37878243 PMC: 10658495. DOI: 10.1111/jvim.16665.
Khalafi M, Sakhaei M, Symonds M, Noori Mofrad S, Liu Y, Korivi M Sports Med Open. 2023; 9(1):50.
PMID: 37382855 PMC: 10310663. DOI: 10.1186/s40798-023-00584-6.
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression.
Guo B, Zhang M, Hao W, Wang Y, Zhang T, Liu C Transl Psychiatry. 2023; 13(1):5.
PMID: 36624089 PMC: 9829236. DOI: 10.1038/s41398-022-02297-y.
Editorial: Long-term effects of hypoxic conditioning on sports performance, health and well-being.
Brocherie F, Timon R Front Physiol. 2022; 13:1112754.
PMID: 36569755 PMC: 9782396. DOI: 10.3389/fphys.2022.1112754.